According to Gram Research analysis, a 2026 study of 2,098 people with prediabetes found that vitamin D supplements reduced diabetes risk by 19%—but only for people with specific genetic variations in their vitamin D receptor gene. People with the AA genetic variation saw no benefit from taking 4,000 IU of vitamin D daily, while those with AC or CC variations showed significant protection. This suggests that genetic testing could help doctors identify who will benefit from vitamin D supplementation to prevent diabetes.
A major study of over 2,000 people with prediabetes found that vitamin D supplements work differently depending on your genes. Researchers discovered that people with certain genetic variations in their vitamin D receptor benefited from taking 4,000 IU of vitamin D daily—cutting their diabetes risk by 19%—while others saw no benefit. This groundbreaking finding suggests that genetic testing could help doctors figure out who should take high-dose vitamin D supplements to prevent diabetes. The research, published in JAMA Network Open, opens the door to personalized medicine where treatments are tailored to your unique genetic makeup.
Key Statistics
A 2026 study of 2,098 adults with prediabetes published in JAMA Network Open found that vitamin D supplementation (4,000 IU daily) reduced diabetes risk by 19% in people carrying AC and CC alleles of the ApaI gene polymorphism, but showed no benefit in those with the AA genotype.
Among 1,480 participants with AC and CC genetic variations, vitamin D supplementation reduced diabetes risk with a hazard ratio of 0.81 (95% CI, 0.66-0.99), while 618 participants with the AA variation showed no response (hazard ratio 1.02).
The Vitamin D and Type 2 Diabetes (D2d) trial followed 2,098 adults with prediabetes for a median of 2.5 years, revealing that genetic variations in the vitamin D receptor determine whether high-dose vitamin D supplements prevent diabetes progression.
The Quick Take
- What they studied: Whether vitamin D supplements prevent diabetes in people with prediabetes, and whether certain genes affect who benefits from the supplements.
- Who participated: 2,098 adults with prediabetes (average age 60 years, about 56% men) who were part of a larger clinical trial that ran from 2013 to 2018.
- Key finding: People with specific genetic variations (AC and CC versions of the ApaI gene) who took 4,000 IU of vitamin D daily had a 19% lower risk of developing diabetes compared to those taking a placebo. However, people with the AA genetic variation saw no benefit from the supplements.
- What it means for you: If you have prediabetes, a simple genetic test might tell you whether high-dose vitamin D supplements could help prevent diabetes. However, this research is still new, and you should talk to your doctor before starting supplements or getting genetic testing.
The Research Details
This was a genetic analysis study that looked at data from a larger clinical trial called the Vitamin D and Type 2 Diabetes (D2d) trial. Researchers took blood samples from 2,098 people with prediabetes and tested them for three common genetic variations in the vitamin D receptor—the protein that helps your body use vitamin D. Half the participants took 4,000 IU of vitamin D3 supplements daily for about 2.5 years, while the other half took a placebo (fake pill). The researchers then looked at who developed diabetes and compared it to their genetic makeup.
The study had two phases. In the first phase, they looked at 1,903 people to understand how different genetic variations affected diabetes risk at different vitamin D levels. In the second phase, they focused on 2,098 people to see how well the supplements worked based on their genes. This two-step approach helps confirm that findings aren’t just due to chance.
The researchers carefully adjusted their results to account for other factors that affect diabetes risk, like age, weight, exercise, and race/ethnicity. This helps ensure that any differences they found were really due to the genes and vitamin D, not other factors.
This research approach is important because it moves beyond the simple question of ‘Does vitamin D help?’ to the more useful question of ‘Who does vitamin D help?’ By identifying specific genetic markers, doctors could eventually use a cheap genetic test to predict which patients will benefit from vitamin D supplements. This is an example of ‘precision medicine’—tailoring treatments to individual patients based on their biology. Without this genetic information, doctors might prescribe vitamin D to everyone with prediabetes, wasting money and time on people it won’t help.
This study has several strengths: it involved over 2,000 people (a large sample), it was a randomized controlled trial (the gold standard for testing treatments), and it was published in a top medical journal (JAMA Network Open). The researchers also used a two-phase approach to confirm their findings, which reduces the chance of false results. However, the study only looked at three genetic variations, and most participants were white, so results might not apply equally to all populations. The study also only tested one dose of vitamin D (4,000 IU), so we don’t know if other doses would work differently.
What the Results Show
The most important finding was that vitamin D supplements worked differently depending on a person’s ApaI gene type. Among the 618 people with the AA genetic variation, taking vitamin D supplements made no difference—their diabetes risk was the same as those taking placebo. But among the 1,480 people with AC or CC genetic variations, vitamin D supplements reduced diabetes risk by 19% compared to placebo. This 19% reduction is meaningful because it suggests that roughly 1 in 5 cases of diabetes could be prevented in this group through vitamin D supplementation.
The study also found that reaching and maintaining higher vitamin D blood levels (40 ng/mL or higher, compared to 20-30 ng/mL) was associated with lower diabetes risk, but only in people with the AC or CC genetic variations. This suggests that the genetic variation affects how well your body responds to vitamin D and uses it to protect against diabetes.
The researchers looked at two other genetic variations (BsmI and FokI) but found they didn’t significantly affect how well vitamin D supplements worked. This suggests that the ApaI variation is the most important genetic factor for determining who benefits from vitamin D supplementation.
The study found that the protective effect of vitamin D was consistent across different groups of people, including men and women, different age groups, and people with different body weights. This suggests that the genetic effect is robust and not limited to specific subgroups. The researchers also found that the benefits appeared over the 2.5-year study period, suggesting that vitamin D supplementation needs time to show its protective effects against diabetes.
Previous research has shown that vitamin D may help prevent diabetes, but results have been mixed. This study adds important new information by showing that genetics play a major role in determining who benefits. Earlier studies didn’t look at genetic variations, which may explain why some studies found vitamin D helpful and others didn’t—they may have included different proportions of people with different genetic types. This research also confirms earlier findings that higher vitamin D blood levels are associated with lower diabetes risk, but now we know this mainly applies to people with certain genetic variations.
The study has several important limitations. First, most participants were white, so the findings might not apply equally to people of other racial or ethnic backgrounds. Second, the study only tested one dose of vitamin D (4,000 IU daily), so we don’t know if other doses would work better or worse for different genetic types. Third, the study only looked at three genetic variations out of many that exist in the vitamin D receptor gene, so other genetic factors might also be important. Fourth, the study was conducted in a research setting where people took supplements regularly and had their blood tested—real-world results might be different. Finally, while the study shows that genetic testing could help identify who benefits from vitamin D, the actual clinical benefit (19% risk reduction) is modest, and more research is needed before genetic testing becomes standard practice.
The Bottom Line
If you have prediabetes, talk to your doctor about whether vitamin D supplementation makes sense for you. According to Gram Research analysis, genetic testing for the ApaI variation could help determine if you’re likely to benefit, but this testing is not yet standard practice. If your doctor recommends vitamin D, a dose of 4,000 IU daily appears safe and may help if you have the AC or CC genetic variations. However, vitamin D supplements should not replace other proven diabetes prevention strategies like weight loss, exercise, and healthy eating. Confidence level: Moderate—this is promising research, but more studies are needed before genetic testing becomes routine.
This research is most relevant to people with prediabetes who are looking for additional ways to prevent diabetes. It’s also important for doctors treating prediabetes, as it suggests a way to personalize treatment. People without prediabetes probably don’t need to worry about this research right now. People with diabetes (not prediabetes) should talk to their doctor before starting vitamin D supplements, as the research doesn’t directly apply to them.
The study followed people for about 2.5 years, so that’s roughly how long it might take to see the protective effects of vitamin D supplementation. However, individual results will vary. Some people might see benefits sooner, while others might take longer. It’s important to be patient and consistent with supplementation if your doctor recommends it.
Frequently Asked Questions
Does vitamin D prevent diabetes in people with prediabetes?
Vitamin D may help prevent diabetes, but it depends on your genes. A 2026 study found that 4,000 IU daily reduced diabetes risk by 19% in people with certain genetic variations (AC and CC alleles), but didn’t help others. Genetic testing could identify who benefits.
What is the ApaI gene and why does it matter for vitamin D?
The ApaI gene variation affects how your body’s vitamin D receptor works. Research shows people with AC or CC versions benefit from vitamin D supplements, while those with AA versions don’t. This genetic difference explains why vitamin D works better for some people than others.
How much vitamin D should I take if I have prediabetes?
The study tested 4,000 IU daily and found it safe and potentially beneficial for people with certain genetic types. However, you should talk to your doctor about the right dose for you, as individual needs vary based on your current vitamin D levels and genetics.
Can I get genetic testing to see if vitamin D will help me?
Genetic testing for the ApaI variation is available through some labs, but it’s not yet standard practice for prediabetes treatment. Talk to your doctor about whether testing makes sense for you and whether your insurance would cover it.
Is vitamin D supplementation better than diet and exercise for preventing diabetes?
No. Diet and exercise are proven to prevent diabetes and should be your first priority. Vitamin D supplementation appears to be an additional tool that might help some people, but it shouldn’t replace weight loss, healthy eating, and regular physical activity.
Want to Apply This Research?
- Track your daily vitamin D supplement intake (yes/no) and your blood vitamin D levels (measured in ng/mL) at regular intervals (every 3-6 months). Also log any changes in fasting blood sugar levels or A1C test results, as these are the key markers of diabetes risk.
- If your doctor recommends vitamin D supplementation based on genetic testing, set a daily reminder to take your 4,000 IU supplement at the same time each day (such as with breakfast). Use the app to log when you take it and note any side effects or changes you notice in how you feel.
- Over 6-12 months, track trends in your blood vitamin D levels and diabetes risk markers (fasting glucose, A1C). Create a monthly check-in to review whether you’re consistently taking supplements and to discuss results with your doctor. If you get genetic testing, save those results in the app for reference during future medical visits.
This research is promising but still emerging. Genetic testing for vitamin D response is not yet standard medical practice. Before starting vitamin D supplements or genetic testing, consult with your healthcare provider, especially if you have prediabetes, take other medications, or have kidney or heart conditions. This article is for educational purposes and should not replace professional medical advice. Individual results may vary based on genetics, lifestyle, and other health factors.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.